Adenovirus in pregnancy is a common respiratory and gastrointestinal infection that is usually mild and self-limiting, but it carries a higher risk of severe pneumonia in pregnant women. Most expectant mothers recover within 5 to 7 days without treatment. The virus spreads through droplets, fecal-oral contact, and contaminated surfaces, and there is no approved antiviral drug for routine cases. Complications are rare but serious: pneumonia occurs in roughly 1 in 1,000 to 1 in 500 adult respiratory adenovirus cases overall, and pregnant women are overrepresented among severe cases. Care focuses on hydration, fever control with acetaminophen, and knowing when to seek help.
How Adenovirus Infects the Body and Why Pregnancy Changes the Response
Adenovirus is a non-enveloped DNA virus with more than 50 known serotypes that cause human disease. It enters through the respiratory tract, the conjunctiva, or the gut lining. The virus binds to cell receptors, inserts its genetic material into the nucleus, and forces the host cell to manufacture viral proteins. Within 24 to 48 hours, the cell ruptures and releases thousands of new viral particles.
The immune system normally contains this within a week. Pregnancy alters that response in measurable ways. Cell-mediated immunity shifts toward a T-helper 2 profile, which is useful for tolerating a fetus but less efficient at clearing intracellular viruses. Natural killer cell activity falls by an estimated 20 to 30 percent in the second and third trimesters. Lung volumes change too: functional residual capacity drops by about 20 percent by late pregnancy, and the diaphragm rises roughly 4 centimeters.
In plain terms: pregnancy tunes the immune system down slightly and compresses the lungs, so a virus that would stay in the nose and throat has an easier path to the lower airways.
The serotype matters. Respiratory serotypes 4 and 7 are the most common causes of adult adenovirus pneumonia. Serotypes 40 and 41 cause gastroenteritis, mostly in young children. Serotype 8 and related strains cause epidemic keratoconjunctivitis, the "pink eye" form.
Quantified Risk: How Often Adenovirus Turns Severe in Pregnancy
Most adenovirus infections in adults are mild upper respiratory illnesses. The severity numbers matter because they frame the entire risk conversation.
| Outcome | General adult population | Pregnant women (estimated) |
|---|---|---|
| Mild respiratory illness | 90-95% of symptomatic cases | 90-95% |
| Pneumonia | 1-2 per 1,000 respiratory cases | 2-4 per 1,000 (estimated) |
| Hospitalization from adenovirus | 0.5-1 per 1,000 cases | 1-2 per 1,000 (estimated) |
| Death from adenovirus pneumonia | 1-5% of pneumonia cases | Up to 10% of pneumonia cases in case series |
| Vertical transmission to fetus | Not applicable | Rare; under 1% in reported cases |
The pneumonia hospitalization figure deserves scrutiny. Adult adenovirus pneumonia is uncommon, but when it occurs it can progress rapidly. A 2019 review of severe adult adenovirus cases found that immunocompromised adults and pregnant women accounted for a disproportionate share of intensive care admissions. The absolute risk remains low. Out of 1,000 pregnant women with symptomatic adenovirus, roughly 2 to 4 will develop pneumonia.
Maternal fever is the mechanism linking infection to fetal risk. Sustained fever above 101 degrees Fahrenheit (38.3 degrees Celsius) in the first trimester is associated with a modestly increased rate of neural tube defects, though the evidence comes from fever of any cause, not adenovirus specifically. A large cohort study estimated the added risk at roughly 1.5 to 3 extra neural tube defects per 1,000 births for first-trimester fever. The takeaway is not that adenovirus causes birth defects; it is that uncontrolled high fever is worth treating.
Fetal transmission is possible but documented rarely. Adenovirus DNA has been found in amniotic fluid and in placental tissue in isolated case reports. No established syndrome of congenital adenovirus infection exists, unlike with cytomegalovirus or Zika. The clinical significance of a positive placental finding is unclear and remains an area of hypothesis rather than established fact.
Trimester-by-Trimester Timeline of Adenovirus Infection
The time course of the illness and the pregnancy stage interact. The table below maps what happens and when.
| Time point | What is happening | What to watch |
|---|---|---|
| Days 0-2 after exposure | No symptoms; virus replicating in respiratory or gut lining | Incubation window; exposure history |
| Days 2-7 | Fever up to 103 F, sore throat, cough, runny nose, red eyes; peak contagiousness | Fever duration; hydration |
| Days 5-10 | Symptoms begin resolving in mild cases; cough may linger 2-3 weeks | Persistent fever past day 5 warrants a call |
| First trimester (weeks 1-13) | Highest concern for fever-related risk; organ formation underway | Any fever above 101 F; treat with acetaminophen |
| Second trimester (weeks 14-27) | Immune shift most pronounced; pneumonia risk rises if infection is severe | Shortness of breath, chest pain, oxygen saturation below 95% |
| Third trimester (weeks 28-40) | Reduced lung capacity; severe illness may prompt early delivery | Breathing difficulty at rest; decreased fetal movement |
| Delivery and postpartum | Vertical transmission remains rare; neonatal adenovirus is usually mild | Newborn fever, poor feeding, lethargy in the first 2 weeks |
Most women clear the infection within 5 to 7 days. The cough can persist for 2 to 3 weeks after the fever resolves because airway inflammation outlasts active viral shedding. Contagiousness typically ends 3 to 5 days after fever breaks, though the virus can shed in stool for weeks.
In the third trimester, a severe respiratory infection is more likely to trigger contractions or preterm labor. This is not specific to adenovirus; it is a general feature of high fever and systemic illness late in pregnancy. Case reports describe preterm delivery in pregnant women with severe adenovirus pneumonia, but causality is difficult to prove.
When Adenovirus Is Not the Only Possibility: Differential Diagnosis
Adenovirus symptoms overlap with several other infections, and the treatment differs. Fever, cough, and sore throat in pregnancy could be influenza, COVID-19, respiratory syncytial virus, or a bacterial infection such as group A streptococcus.
Several clues point toward adenovirus specifically. Conjunctivitis combined with pharyngitis, sometimes called pharyngoconjunctival fever, is a classic adenovirus pattern. Gastroenteritis with watery diarrhea and no blood is more consistent with adenovirus types 40 and 41. High fever that lasts 5 or more days without respiratory improvement raises concern for pneumonia or a bacterial complication.
Influenza is the most important alternative to rule out. Pregnant women are a high-risk group for influenza complications, and antiviral treatment with oseltamivir is recommended within 48 hours of symptom onset. Per the CDC, pregnant women with suspected influenza should start treatment empirically without waiting for test results. This contrasts with adenovirus, where no routine antiviral exists.
COVID-19 remains a consideration as well. Rapid antigen tests are widely available and distinguish the two within 15 minutes. A negative result does not rule out adenovirus, because adenovirus testing is not routine outside hospitals.
Red Flags: Symptoms That Require Immediate Medical Attention
Most adenovirus infections do not need a doctor visit. The exceptions matter.
- Shortness of breath at rest, or oxygen saturation below 95 percent on a home pulse oximeter
- Chest pain that worsens with breathing, or a cough producing blood
- Fever above 103 F that does not respond to acetaminophen within 2 hours
- Persistent fever lasting more than 5 days, or fever that returns after improving
- Decreased fetal movement, vaginal bleeding, or regular contractions before 37 weeks
- Severe dehydration: inability to keep fluids down, dizziness on standing, or dark urine
Any of these warrants same-day contact with a clinician. In pregnancy, the threshold for evaluation should be lower than for the general population. A woman with mild adenovirus who develops a new cough with breathlessness may have progressed to pneumonia and needs imaging, typically a chest X-ray with abdominal shielding.
Managing Adenovirus in Pregnancy: What to Actually Do
There is no approved antiviral for adenovirus. Cidofovir exists and is used in immunocompromised patients with severe disease, but it carries kidney toxicity and is not recommended for routine or mild cases in pregnancy. Management is supportive.
- Rest and hydrate. Aim for pale yellow urine as a hydration check. Water, broth, and oral rehydration solutions are all appropriate.
- Treat fever with acetaminophen at standard adult doses, up to 3,000 milligrams per day, taken as directed. Avoid ibuprofen and aspirin unless a clinician specifically approves them in pregnancy.
- Isolate at home for 3 to 5 days after fever breaks. Wash hands frequently and use separate towels, since adenovirus survives on surfaces for hours to days.
- Call your obstetric provider early rather than late. Report the fever duration and any breathing changes. Most cases need no in-person visit.
- Do not demand antibiotics. Adenovirus is viral, and antibiotics do nothing except add side effects.
- Monitor fetal movement daily after 28 weeks. A change in the pattern is a reason to call, not to wait.
The one preventive measure with strong evidence for adenovirus in closed settings is hand hygiene; there is no vaccine approved for civilian use. The oral adenovirus vaccine types 4 and 7 are licensed only for military populations ages 17 to 50 and are not available to pregnant women. The 2023 Cochrane review of hand hygiene interventions found that consistent handwashing reduced respiratory infection rates by roughly 15 to 20 percent in household settings, which is the best available evidence for prevention here.
Limitations: What the Evidence Does Not Tell Us
Several important questions lack high-quality answers. Pregnancy-specific adenovirus data come almost entirely from case reports and small case series, not from controlled trials. The pneumonia risk figures above are extrapolated from adult and immunocompromised populations and should be read as estimates, not measurements.
Whether adenovirus directly crosses the placenta and causes fetal harm is not established. The occasional positive findings in amniotic fluid suggest it can happen, but no causal congenital syndrome has been described. This remains hypothesis-level knowledge.
The interaction between adenovirus and pregnancy complications such as preeclampsia or intrauterine growth restriction is unstudied. Any link would be speculative. The mechanism by which pregnancy raises severe-illness risk is inferred from general immunology, not from adenovirus-specific studies.
One practical caveat: cough syrups and combination cold medicines sold over the counter often contain ingredients not well studied in pregnancy, including dextromethorphan and certain antihistamines. Plain acetaminophen, rest, fluids, and honey for cough have better safety profiles than multi-ingredient formulations.
Finally, the numbers must reconcile. A 2 to 4 per 1,000 pneumonia risk in symptomatic pregnant women is higher than the 1 to 2 per 1,000 rate in the general adult population, but both are far below the rate seen in transplant patients, where adenovirus pneumonia can occur in up to 5 to 10 percent of cases. The gap between these figures reflects immune status, not virus changes. For the average pregnant woman with a normal immune system, mild adenovirus is the expected outcome; severe disease is the exception that good monitoring is designed to catch early.